OBJECTIVE: The effect of recombinant murine granulocyte macrophage colony-stimulating factor (rmGM-CSF) on survival and host defense was studied using two clinically relevant models of infection that included transfusion-induced immunosuppression. SUMMARY BACKGROUND DATA: Granulocyte macrophage colony-stimulating factor improves resistance in several models of infection, but its role in transfusion-induced immunosuppression and bacterial translocation (gut-derived sepsis) has not been defined. METHODS: Balb/c mice were treated with 100 ng of rmGM-CSF or placebo for 6 days in a model of transfusion, burn, and gavage, or cecal ligation and puncture (CLP). Translocation was studied in the first model. RESULTS: Survival after transfusion, burn, and gavage was 90% in rmGM-CSF-treated animals versus 35% in the control group (p < 0.001). After CLP, survival was 75% in the rmGM-CSF group versus 30% in the control group (p = 0.01). Less translocation and better killing of bacteria was observed in the tissues in animals treated with rmGM-CSF. CONCLUSION: The ability of rmGM-CSF to improve gut barrier function and enhance killing of translocated organisms after burn injury-induced gut origin sepsis was associated with improved outcome. Granulocyte macrophage colony-stimulating factor also improved survival after CLP.
OBJECTIVE: The effect of recombinant murinegranulocyte macrophage colony-stimulating factor (rmGM-CSF) on survival and host defense was studied using two clinically relevant models of infection that included transfusion-induced immunosuppression. SUMMARY BACKGROUND DATA: Granulocyte macrophage colony-stimulating factor improves resistance in several models of infection, but its role in transfusion-induced immunosuppression and bacterial translocation (gut-derived sepsis) has not been defined. METHODS: Balb/c mice were treated with 100 ng of rmGM-CSF or placebo for 6 days in a model of transfusion, burn, and gavage, or cecal ligation and puncture (CLP). Translocation was studied in the first model. RESULTS: Survival after transfusion, burn, and gavage was 90% in rmGM-CSF-treated animals versus 35% in the control group (p < 0.001). After CLP, survival was 75% in the rmGM-CSF group versus 30% in the control group (p = 0.01). Less translocation and better killing of bacteria was observed in the tissues in animals treated with rmGM-CSF. CONCLUSION: The ability of rmGM-CSF to improve gut barrier function and enhance killing of translocated organisms after burn injury-induced gut origin sepsis was associated with improved outcome. Granulocyte macrophage colony-stimulating factor also improved survival after CLP.
Authors: F Bussolino; M Ziche; J M Wang; D Alessi; L Morbidelli; O Cremona; A Bosia; P C Marchisio; A Mantovani Journal: J Clin Invest Date: 1991-03 Impact factor: 14.808
Authors: Philipp J Rauch; Aleksey Chudnovskiy; Clinton S Robbins; Georg F Weber; Martin Etzrodt; Ingo Hilgendorf; Elizabeth Tiglao; Jose-Luiz Figueiredo; Yoshiko Iwamoto; Igor Theurl; Rostic Gorbatov; Michael T Waring; Adam T Chicoine; Majd Mouded; Mikael J Pittet; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski Journal: Science Date: 2012-01-12 Impact factor: 47.728
Authors: Balázs Csóka; Zoltán H Németh; Ildikó Szabó; Daryl L Davies; Zoltán V Varga; János Pálóczi; Simonetta Falzoni; Francesco Di Virgilio; Rieko Muramatsu; Toshihide Yamashita; Pál Pacher; György Haskó Journal: JCI Insight Date: 2018-06-07
Authors: Stefanie N Linch; Erin T Danielson; Ann M Kelly; Raina A Tamakawa; James J Lee; Jeffrey A Gold Journal: Am J Respir Crit Care Med Date: 2012-05-31 Impact factor: 21.405
Authors: Rebecca A Drummond; Jigar V Desai; Emily E Ricotta; Muthulekha Swamydas; Clay Deming; Sean Conlan; Mariam Quinones; Veronika Matei-Rascu; Lozan Sherif; David Lecky; Chyi-Chia R Lee; Nathaniel M Green; Nicholas Collins; Adrian M Zelazny; D Rebecca Prevots; David Bending; David Withers; Yasmine Belkaid; Julia A Segre; Michail S Lionakis Journal: Cell Host Microbe Date: 2022-05-13 Impact factor: 31.316
Authors: J L Grosfeld; M Chaet; F Molinari; W Engle; S A Engum; K W West; F J Rescorla; L R Scherer Journal: Ann Surg Date: 1996-09 Impact factor: 12.969